SBIR/STTR Research Award

Preventing Pneumothorax During Transthoracic Lung Biopsy

Award identifier 95e2af5718525e7ad7504780fc8651ec1f8d53a8c2ad0b985fe3124151824961Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$147,147

Program and phase

SBIR · Phase I

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CAMBRIDGE POLYMER GROUP INC
Proposal award date
2019-09-18
Contract end date
2020-09-17
UEI
DKJDB8BKRGB3
Solicitation number
PA18-574
Topic code
NCI

Research abstract

Project Summary Annuallyovermillion CT guided lung biopsies are performed worldwide for lung cancer diagnosisin the USPneumothoraxPTXa collapsed lungis the most common complication of this procedureoccurring inof all CT guided lung biopsiesInof lung biopsiesthe patient becomes symptomatic due to PTX and requires an invasive chest tube insertionthe definitive treatment for PTXThis complication costson an average$k per chest tube insertion and $billion worldwide to treatThis turns a same day diagnostic procedure into a multi day hospitalizationIn addition to extreme respiratory distress to patientsit is inconvenient for radiologists to managePTX arises when air from the lungs or external environment enters the area between the chest wall and lungs during or after needle insertion due to a pressure differenceA recent time dependent analysis ofpatients undergoing CT guided lung biopsy demonstrated thatof PTX occur while the needle is insertedmeaning air is actively leaking during the procedureSeveral methods are used for preventing PTX due to biopsyincluding only FDA approved deviceblood saline patch and air aspirationAll of these methodshoweverare for application to the puncture site once the biopsy is complete and therefore relatively ineffectiveandltAdditionallythey add timeandgtminsand stepsandgtto the procedureThe development of a novel biopsy needle tract biosealant that will reduce or eliminate pneumothorax would be most valuableThe focus of the current investigation is to evaluate and demonstrate the possibility of using a biosealant and delivery device to seal needle tracts to prevent PTX during transthoracic lung biopsyFurtherwin vitro and in vivo preliminary biocompatibility of the material as well as efficacy of the delivery device as compared to the current standard of care Project Narrative This research will support the development of a medical device that will help clinicians reduce lung collapse rates during transthoracic lung biopsywhich will improve patient outcomes and satisfaction while reducing medical costs

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

13 SBIR/STTR records share this UEI (1997–2022). Reported award amounts total $3,469,773. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation, Department of Commerce

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.